 Connection
Andrew Goodwin to United States Food and Drug Administration
This is a "connection" page, showing publications Andrew Goodwin has written about United States Food and Drug Administration.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.098 |
|
|
|
-
Shendre A, Liu X, Chiang C, Goodwin A, Oteng SR, Deypalubos JAF, Zhang S, Wang L, Liu J, Abbasi MY, Aruldhas BW, Zaidi SS, Kirkpatrick LM, Silva LD, Overholser BR, O'Kane AM, Kannankeril PJ, Patrick SW, Wiese AD, Quinney SK, Li L. Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations. Pharmacotherapy. 2025 06; 45(6):367-385.
Score: 0.053
-
Ackley D, Birkebak J, Blumel J, Bourcier T, de Zafra C, Goodwin A, Halpern W, Herzyk D, Kronenberg S, Mauthe R, Shenton J, Shuey D, Wange RL. FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations. Regul Toxicol Pharmacol. 2023 Feb; 138:105327.
Score: 0.045
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|